Description

Reneuro (Choline Alfoscerate) Solution for Injections 250 mg/ml. 4 ml. Ampoules №5

Ingredients:

Each 4 ml ampoule contains 250 mg of Choline Alfoscerate as the active ingredient.

Dosage:

The recommended dosage is determined by a healthcare professional and administered via intramuscular or intravenous injection.

Indications:

Reneuro is indicated for the treatment of cognitive disorders and memory impairments associated with various neurological conditions.

Contraindications:

Do not use Reneuro if you are allergic to Choline Alfoscerate or any other ingredients in the solution.

Directions:

Administer Reneuro as directed by a healthcare provider. Do not exceed the recommended dosage or frequency of administration.

Scientific Evidence:

Choline Alfoscerate, the active ingredient in Reneuro, has been studied for its cognitive-enhancing properties. Research suggests that Choline Alfoscerate may improve memory, attention, and overall cognitive function in individuals with cognitive impairment.

Studies have shown that Choline Alfoscerate acts as a precursor to acetylcholine, a neurotransmitter involved in memory and learning. By increasing acetylcholine levels in the brain, Choline Alfoscerate may support cognitive function and help alleviate symptoms of cognitive decline.

Additional Information:

• Reneuro is well-tolerated in most individuals, but common side effects may include gastrointestinal discomfort or headache.
• It is important to store Reneuro ampoules in a cool, dry place away from direct sunlight.